Phase 3 trial shows trastuzumab deruxtecan extends survival by over three months in advanced HER2-positive gastric cancer and ...

Early comprehensive geriatric assessment improves hip fracture recovery, reducing complications, hospital stay, and mortality in older adults, according to a systematic review of 39 studies.

Vepdegestrant may prolong progression-free survival in ESR1-mutated, ER-positive, HER2-negative advanced breast cancer, ...

A 14-gene molecular assay may help identify early-stage non-squamous NSCLC patients who benefit from chemotherapy ...

Discover how catheter ablation performs in congenital heart disease - find out more about the latest nationwide results.

Phase 3 trial evaluates encorafenib, cetuximab, and chemotherapy in untreated BRAF V600E-mutant metastatic colorectal cancer, ...

Discover a study that found that the proportion of radical prostatectomies fell from 32.4% in 2010 to just 7.8% by 2020.